The QD Syringe Platform

Reimagining Medication Preparation for the Modern Healthcare System

For more than six decades, the basic disposable syringe has remained largely unchanged. While medicine has advanced dramatically with biotechnology, precision therapeutics, robotic surgery, and personalized medicine the disposable syringe continues to perform much as it did generations ago. Healthcare professionals have adapted by surrounding the syringe with an ever growing collection of accessory devices: steel fill needles, blunt fill needles, plastic vial access cannulas, transfer devices, injection needles, blood collection devices, arterial blood gas syringes, and specialty connectors. Rather than redesigning the syringe itself, the industry has continually added products to compensate for its limitations.

The QD Syringe Platform was conceived from a simple but fundamental question:

Why should a disposable syringe require another device before it becomes functional?

That question became the foundation of a completely new approach to medication preparation and delivery.

The Functional Syringe

Unlike a conventional disposable syringe, which requires a separate draw needle or vial access device before medication can be withdrawn, the QD Syringe incorporates an integrated blunt acrylic cannula that allows immediate access to rubber-stopper medication vials directly from its sterile package.

This seemingly simple design change transforms the syringe from a passive container into a functional medication preparation system.

The practitioner opens one package, accesses the medication vial, withdraws the medication, attaches the dedicated low dead space injection hub, and administers the medication all without requiring a separate fill needle.

The result is a simplified workflow that has the potential to reduce device changes, inventory, hazardous sharps, medication preparation time, and unnecessary complexity.

Low Dead Space Medication Delivery

One of the primary objectives of the QD Syringe is reducing medication waste.

Conventional detachable needle syringes contain residual volume within the hub connection after injection. This "dead space" traps medication that never reaches the patient. While the amount may appear small, published research has demonstrated that dead-space losses become economically significant when expensive injectable medications are administered repeatedly.

Independent researchers from the University of North Carolina at Chapel Hill and RTI International concluded that low dead-space syringe designs can reduce preventable medication waste dramatically and recommended broader adoption of low dead-space technology as an industry standard.

The QD Syringe builds upon this concept by combining a low dead-space delivery system with detachable needles and integrated vial-access capability features not traditionally combined within a single disposable syringe platform.

The economic implications extend across numerous clinical specialties, including oncology, biologics, hormone replacement therapy, nuclear medicine, specialty pharmacy, and aesthetic medicine.

A Syringe Designed Specifically for Medication Preparation

Conventional hypodermic needles were designed primarily to penetrate human tissue. Over time they also became the standard tool for drawing medication from vials, even though fluid transfer presents a completely different engineering problem.

The QD integrated cannula was designed specifically for medication preparation.

Its bilateral side channels permit medication to enter from opposing sides rather than relying solely on a distal opening. Rather than repeatedly manipulating a steel draw needle to chase medication trapped beneath recessed vial stoppers, the QD Cannula is intended to remain at its stopping point while medication is withdrawn in one continuous motion.

This design philosophy separates medication preparation from patient injection, allowing each component to be optimized for its intended purpose.

Complete Medication Recovery

Many injectable medications are packaged in expensive multi-dose or single-dose vials.

Current steel draw needles often require repeated repositioning, tilting, and manipulation to recover the remaining medication beneath thick rubber stoppers or recessed vial designs.

The QD Cannula was designed to simplify this process by providing immediate access to medication throughout the vial while reducing manipulation during withdrawal. This design objective is particularly attractive for expensive medications where every microliter has measurable economic value.

Applications include:

• Oncology medications
• Biologic therapies
• Hormone replacement medications
• Specialty injectables
• Botulinum toxin products
• Nuclear medicine pharmaceuticals
• Compounded medications

Streamlining Medication Reconstitution

Medication reconstitution is one of the most repetitive procedures performed in healthcare.

Pharmacists, nurses, anesthesia providers, and nuclear medicine technologists routinely prepare medications requiring multiple devices and repeated manipulation.

The QD Platform was designed to simplify medication reconstitution by eliminating the separate draw needle while maintaining familiar clinical technique.

Its bilateral channel design also produces a different fluid flow pattern than a conventional steel needle. Rather than directing a concentrated stream directly through the needle tip, fluid exits through opposing side channels toward the vial wall. This flow characteristic may offer advantages for certain delicate medications, although this would require formal validation.

Nuclear Medicine

Radiopharmaceuticals represent some of the most expensive injectable medications in healthcare.

Every drop recovered has financial value, while minimizing spills and handling is essential for staff safety.

The QD Platform offers several potential advantages within nuclear medicine:

• Simplified medication reconstitution.
• Elimination of a separate steel fill needle.
• Short integrated vial-access tip.
• Continuous pressure management while the syringe remains inserted.
• Efficient withdrawal of valuable radiopharmaceuticals.

The platform also introduces opportunities for reducing workflow complexity during shielded vial preparation.

Hormone Replacement Therapy and Specialty Clinics

Feedback from hormone replacement patients and specialty clinics consistently identifies medication waste and multiple needle changes as significant frustrations.

Patients commonly use a large steel draw needle to withdraw medication before replacing it with a separate injection needle.

The QD Platform simplifies this workflow by integrating vial access directly into the syringe, eliminating the separate draw needle while preserving a fresh injection needle that has never contacted a rubber stopper.

Preserving Injection Needle Performance

Traditional injection needles frequently perform two jobs:

• Penetrating the medication vial.
• Penetrating the patient's tissue.

The QD Platform separates these functions.

The injection needle is reserved exclusively for patient administration.

Because it never contacts the rubber stopper during medication preparation, the needle's tip geometry and lubrication remain intact prior to patient use, potentially preserving penetration characteristics and patient comfort.

Addressing Rubber Coring

Published literature has demonstrated that steel needles may remove fragments of rubber from medication vial stoppers under certain conditions.

The incidence varies depending upon device geometry, needle design, insertion technique, and stopper characteristics.

The integrated QD Cannula was designed with a non-coring objective, eliminating the need for a separate steel draw needle. While dedicated comparative testing would be required to quantify performance, reducing opportunities for rubber particulate generation represents another important design goal.

Medication Safety and Workflow

The QD Platform was developed to simplify medication preparation by reducing reliance on multiple accessory devices.

Potential benefits include:

• Elimination of separate draw needles.
• Reduced sharps handling.
• Fewer device exchanges.
• Lower hazardous waste.
• Reduced inventory requirements.
• Simplified medication rooms.
• Improved pharmacy workflow.
• Faster medication preparation.

These workflow improvements may become increasingly important as healthcare systems seek to reduce labor costs while improving efficiency.

Compatibility with Existing Clinical Practice

Rather than requiring healthcare providers to abandon familiar techniques, the QD Platform was designed to integrate into existing workflows.

The system has been envisioned for use across numerous clinical applications including:

• Hospital pharmacy.
• Bedside nursing.
• Emergency medicine.
• Intensive care.
• Oncology.
• Nuclear medicine.
• Hormone replacement therapy.
• Compounding pharmacies.
• Aesthetic medicine.
• Blood collection.
• Arterial blood gas sampling.
• Needleless IV systems where compatible.

The modular architecture allows specialized hubs and accessories to be developed for specific clinical applications while preserving a common low dead-space syringe platform.

A Platform Rather Than a Product

Perhaps the greatest innovation of the QD concept is that it is not simply a new syringe.

It is a modular medication preparation platform.

Its architecture allows multiple products to be developed from the same core technology:

• QD Low Dead Space Syringe.
• QD Universal Cannula.
• QD Butterfly Blood Collection System.
• QD Blood Gas Syringe.
• QD Pharmacy System.
• QD Nuclear Medicine System.
• QD Medication Preparation Kits.

Each product shares the same underlying philosophy: separate clinical functions so each component can be optimized for its intended purpose.

Looking Forward

The QD Platform represents a vision for the next generation of disposable medication preparation technology.

Its objectives are ambitious:

• Reduce medication waste.
• Simplify medication preparation.
• Improve pharmacy efficiency.
• Reduce hazardous sharps.
• Lower inventory requirements.
• Improve patient comfort.
• Reduce opportunities for rubber coring.
• Preserve injection needle performance.
• Expand low dead space technology beyond fixed-needle syringes.
• Create a modular platform adaptable to multiple areas of healthcare.

Some of these objectives are already supported by published literature on low dead space, medication waste, and vial coring. Others represent engineering hypotheses that will require additional bench testing, human factors studies, economic analysis, and clinical validation.

Together, however, they define a new philosophy for medication preparation one that challenges the assumption that a disposable syringe should remain dependent upon multiple accessory devices.

The QD Platform is not simply an incremental improvement to an existing syringe. It is an effort to rethink how medication is prepared, transferred, and delivered throughout modern healthcare, with the goal of creating a safer, more efficient, and more economical system for clinicians and patients alike.